CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The SAFER project focuses on improving drug safety by enhancing the detection of adverse drug effects through advanced information technology methods. It aims to integrate various pharmacovigilance signal sources to minimize false positives and improve the reliability of drug safety signals.
Adverse drug effects endanger patients’ safety and cause considerable extra healthcare costs.
The procedures of drug surveillance and drug harm prevention are studied by pharmacovigilance.
Several Information Technology (IT) methods are currently employed for conducting research as regards identification of pharmacovigilance signals.
The current project (SAFER) will elaborate on exploiting and complementing evidence obtained from various types of existing pharmacovigilance signal sources through…
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
